Fisher A, Brandeis R, Pittel Z, Haring R, Sparks L, Beach TG, Bons N, Maestre-Frances N, Bar-Ner N, Kliger-Spatz M, Natan N, Marcovitch I, Hartmann T (2004)
Poster (46) Major hallmarks in alzheimer's disease (ad) can beneficially be modulated by M1 muscarinic agonists - an added value vs. cholinesterase inhibitors
In: Cholinesterases in the Second Millennium: Biomolecular and Pathological Aspects (Inestrosa NC, Campos EO) P. Universidad Catolica de Chile-FONDAP Biomedicina: 345

Pittel Z, Haring R, Bons N, Bar-Ner N, Sonego H, Natan N, Marcovitch I, Brandeis R (2004)
Beta-amyloids, tau hyperphosphorylation and cognition are beneficially affected by M1 muscarinic agonists.
Cholinergic Mechanisms, CRC Press

Fisher A, Pittel Z, Haring R, Bar-Ner N, Kliger-Spatz M, Natan N, Egozi I, Sonego H, Marcovitch I, Brandeis R (2003)
M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy
Journal of Molecular Neuroscience 20: 349

Fisher A, Michaelson DM, Brandeis R, Haring R, Chapman S, Pittel Z (2000)
M1 muscarinic agonists as potential disease-modifying agents in Alzheimer's disease. Rationale and perspectives
Annals of the New York Academy of Sciences 920: 315

Pittel Z, Fisher A, Eshhar N, Haring R, Heldman E (1999)
Poster: Effect of muscarinic stimulation on beta-amyloid precursor protein processing in rat brain and primary cultures
Life Sciences 64: 572

Fisher A, Brandeis R, Haring R, Eshhar N, Heldman E, Karton Y, Eisenberg O, Meshulam H, Marciano D, Bar-Ner N, Pittel Z (1998)
Novel m1 muscarinic agonists in treatment and delaying the progression of Alzheimer's disease: An unifying hypothesis
Journal de Physiologie (Paris) 92: 337

Haring R, Eshhar N, Heldman E, Marciano D, Kloog Y, Fisher A (1997)
Poster: An M1 selective agonist AF102b, as a potential drug in treatment of Alzheimer's disease: Biochemical and pharmacological properties
Life Sciences 60: 1183

Danenberg HD, Haring R, Fisher A, Pittel Z, Gurwitz D, Heldman E (1996)
Dehydroepiandrosterone (DHEA) increases production and release of Alzheimer's amyloid precursor protein
Life Sciences 59: 1651

Fisher A, Heldman E, Gurwitz D, Haring R, Karton Y, Meshulam H, Pittel Z, Marciano D, Brandeis R, Sadot E, Barg Y, Pinkas-Kramarski R, Vogel Z, Ginzburg I, Treves TA, Verchovsky R, Klimowsky S, Korczyn AD (1996)
M1 agonists for the treatment of Alzheimer's disease. Novel properties and clinical update
Annals of the New York Academy of Sciences 777: 189

Pittel Z, Heldman E, Barg J, Haring R, Fisher A (1996)
Muscarinic control of amyloid precursor protein secretion in rat cerebral cortex and cerebellum
Brain Research 742: 299

Danenberg HD, Haring R, Heldman E, Gurwitz D, Ben-Nathan D, Pittel Z, Zuckerman A, Fisher A (1995)
Dehydroepiandrosterone augments M1-muscarinic receptor-stimulated amyloid precursor protein secretion in desensitized PC12M1 cells
Annals of the New York Academy of Sciences 774: 300

Gurwitz D, Haring R, Heldman E, Fraser CM, Manor D, Fisher A (1994)
Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands
European Journal of Pharmacology 267: 21

Fisher A, Heldman E, Gurwitz D, Haring R, Barak D, Meshulam H, Marciano D, Brandeis R, Pittel Z, Segal M, et al. (1993)
Selective signaling via unique M1 muscarinic agonists
Annals of the New York Academy of Sciences 695: 300

Fisher A, Karton Y, Heldman E, Gurwitz D, Haring R, Meshulam H, Brandeis R, Pittel Z, Segall Y, Marciano D, et al. (1993)
Progress in medicinal chemistry of novel selective muscarinic agonists
Drug Des Discov 9: 221

Fisher A, Brandeis R, Karton I, Pittel Z, Gurwitz D, Haring R, Sapir M, Levy A, Heldman E (1991)
(+-)-cis-2-methyl-spiro(1,3-oxathiolane-5,3')quinuclidine, an M1 selective cholinergic agonist, attenuates cognitive dysfunctions in an animal model of Alzheimer's disease
Journal of Pharmacology & Experimental Therapeutics 257: 392

Mosckovitz R, Haring R, Gershoni JM, Kloog Y, Sokolovsky M (1987)
Localization of azidophencyclidine-binding site on the nicotinic acetylcholine receptor alpha-subunit
Biochemical & Biophysical Research Communications 145: 810